Physician profile
John Hinze
NPI 1013933019
$28,353.27
in general payments reported to CMS, 2019-2025
22 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,570 · 2020: $693 · 2021: $63.40 · 2022: $5,249 · 2023: $7,523 · 2024: $8,038 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Consulting Fee: $6,075 · Travel and Lodging: $980 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Consulting Fee | $6,075.00 |
| Travel and Lodging | $979.68 |
| Food and Beverage | $723.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,457.71 | 2022-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Ambu INC. | $6,075.00 | 2023-2024 | |
| Pfizer INC. | $2,833.33 | 2019-2020 | |
| Pulmonx Corporation | $1,708.40 | 2019-2022 | |
| Conmed Corporation | $1,000.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $500.00 | 2019 | |
| Covidien LP | $250.69 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $243.69 | 2019-2020 | |
| Glaxosmithkline, LLC. | $210.46 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.08 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $147.54 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $145.12 | 2019 | |
| Olympus America INC. | $128.11 | 2025 | |
| Steris Corporation | $89.04 | 2025 | |
| Mylan Specialty L.P. | $76.61 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $68.27 | 2019-2022 | |
| Medtronic, INC. | $67.76 | 2022 | |
| Genzyme Corporation | $64.98 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $45.21 | 2019-2020 | |
| Genentech USA, INC. | $41.01 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.77 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hinze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.